IGC Pharma Income Statement (2010-2025) | IGC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue (Quarter)	0.11M	0.08M	0.08M	0.06M	0.14M	0.12M	0.21M	0.20M	0.33M	0.17M	0.56M	0.29M	0.20M	0.29M	0.27M	0.41M	0.26M	0.33M	0.33M	0.19M
Cost of Revenue (Quarter)	0.09M	0.05M	0.05M	0.02M	0.08M	0.05M	0.07M	0.07M	0.23M	0.10M	0.30M	0.12M	0.07M	0.12M	0.11M	0.21M	0.15M	0.18M	0.17M	0.09M
Gross Profit (Quarter)	0.01M	0.03M	0.03M	0.04M	0.06M	0.07M	0.14M	0.14M	0.10M	0.06M	0.26M	0.17M	0.13M	0.17M	0.16M	0.20M	0.10M	0.15M	0.15M	0.10M
Operating items
Amortization - Intangibles (Quarter)
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	0.15M	0.30M	0.44M	0.28M	0.38M	1.23M	1.39M	0.77M	0.81M	0.53M	0.75M	1.27M	0.90M	0.88M	0.89M	0.92M	0.85M	1.00M	0.85M	1.59M
Selling, General & Administrative (Quarter)	2.19M	2.48M	1.78M	4.11M	2.07M	5.34M	1.55M	1.85M	1.57M	3.61M	1.65M	1.40M	2.23M	1.49M	1.67M	1.04M	1.13M	0.57M	1.21M	1.41M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	2.34M	2.79M	2.22M	4.39M	2.45M	6.57M	2.94M	2.62M	2.38M	4.14M	2.39M	2.67M	3.13M	2.37M	2.56M	1.96M	1.98M	1.57M	2.06M	3.00M
Operating Income (Quarter)	-2.33M	-2.79M	-2.19M	-4.35M	-2.38M	5.77M	-2.80M	-2.49M	-2.28M	-4.04M	-2.14M	-2.49M	-3.00M	4.90M	-2.40M	-1.76M	-1.88M	-1.41M	-1.91M	-2.90M
EBIT (Quarter)	-2.33M	-2.79M	-2.19M	-4.35M	-2.38M	5.77M	-2.80M	-2.49M	-2.28M	-4.04M	-2.14M	-2.49M	-3.00M	4.90M	-2.40M	-1.76M	-1.88M	-1.41M	-1.91M	-2.90M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.00M	-0.05M	0.44M	0.00M	0.00M	0.01M	0.02M	0.05M	0.03M	0.03M	0.06M	0.04M	0.03M	-0.14M	0.02M	0.04M	0.05M	0.21M	0.31M	1.08M
Non Operating Income (Quarter)	0.00M	0.01M	0.44M	0.00M	0.00M	0.01M	0.02M	0.05M	0.03M	0.01M	0.06M	0.04M	0.03M	0.01M	0.02M	0.04M	0.05M	0.21M	0.31M	1.08M
Net income details
EBT (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Consolidated Net Income (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Income towards Parent Company (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Net Income towards Common Stockholders (Quarter)	-2.32M	-2.95M	-1.79M	-4.34M	-2.38M	-6.50M	-2.79M	-2.44M	-2.25M	-4.03M	-2.08M	-2.45M	-5.59M	-2.88M	-2.38M	-1.72M	-1.83M	-1.20M	-1.60M	-1.82M
Additional items
EPS (Basic) (Quarter)	-0.06	-0.07	-0.04	-0.09	-0.05	-0.13	-0.05	-0.05	-0.04	-0.08	-0.04	-0.05	-0.09	-0.04	-0.03	-0.02	-0.02	-0.01	-0.02	-0.02
EPS (Weighted Average and Diluted) (Quarter)												-0.05	-0.09	-0.04	-0.03	-0.02	-0.02	-0.01	-0.02	-0.02
Shares Outstanding (Weighted Average) (Quarter)	40.92M	41.96M	47.91M	48.94M	49.64M	49.99M	51.62M	52.19M	52.41M	52.58M	53.08M	54.30M	57.04M	58.84M	72.81M	74.42M	77.63M	76.52M	83.03M	86.76M
Shares Outstanding (Diluted Average) (Quarter)												53.70M	57.04M	58.84M	72.81M	74.42M	75.49M	76.52M	83.03M	90.46M
EBITDA (Quarter)	-2.28M	-3.00M	-1.87M	-4.32M	-2.30M	-6.71M	-3.00M	-2.62M	-2.31M	-3.99M	-2.07M	-2.51M	-5.57M	-2.88M	-2.38M	-1.73M	-1.85M	-1.19M	-1.60M	-1.84M
Interest Expenses (Quarter)
Tax Rate (Quarter)

Research Tools

IGC Pharma Income Statement (2010-2025) | IGC

Create an account

Sign In

Reset Password